Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL721492 | 0.86 | TSHR (0.44) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL5161658 | 0.75 | — | — | |
| SCHEMBL11615225 | 0.73 | THRB (0.37) | — | |
| SCHEMBL27955734 | 0.73 | THRB (0.61) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL3856267 | 0.73 | THRB (0.61) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL5159672 | 0.69 | TSHR (0.54) | TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL1259288 | 0.69 | — | — | |
| SCHEMBL5694078 | 0.69 | TSHR (0.41) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL6700786 | 0.69 | TSHR (0.35) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL8587661 | 0.68 | TSHR (0.33) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080070904-A1 | Pharmaceutical compositions of benzodiazepines and method of use thereof | JAZZ PHARMACEUTICALS (US) | 2008-03-20 | — | — | US | claimed |
| US-7249723-B2 | Organic solvent dispersed nano-talc slurry | NGX, INC. (US) | 2007-07-31 | — | — | US | claimed |
| WO-2007024252-A2 | ORGANIC SOLVENT DISPERSED NANO-TALC SLURRY | NANOMAT, INC. (US) | 2007-03-01 | — | — | WO | claimed |
| US-20060086837-A1 | Dry milling talc powder, mixing the dry-milled nano-talc powder with an organic solvent andwet milling the nano-talc-solvent mix | NGX, INC. | 2006-04-27 | — | — | US | claimed |
| US-20050228191-A1 | Method for preparing hydroxystyrenes and acetylated derivatives thereof | E. I. DU PONT DE NEMOURS AND COMPANY | 2005-10-13 | — | — | US | claimed |
| US-20240059731-A1 | Method for Biomaterial Purification and Kits Thereof | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2024-02-22 | — | — | US | disclosed |
| CN-117546314-A | Negative electrode composition, negative electrode for lithium secondary battery comprising same, lithium secondary battery comprising negative electrode, and method for producing negative electrode composition | 株式会社LG新能源 | 2024-02-09 | — | — | CN | disclosed |
| EP-3997163-B1 | FILLER FOR 3D PRINTING | QUARZWERKE GMBH (DE) | 2023-09-06 | — | — | EP | disclosed |
| CN-115521672-B | Water-based environment-friendly aluminum foil varnish and preparation method thereof | 浙江特美新材料股份有限公司 | 2023-09-05 | — | — | CN | disclosed |
| US-20230174688-A1 | COMPOUND, (CO)POLYMER, COMPOSITION, METHOD FOR FORMING RESIST PATTERN, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING (CO)POLYMER | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-06-08 | — | — | US | disclosed |
| WO-2021105864-A1 | METHOD FOR BIOMATERIAL PURIFICATION AND KITS THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2021-06-03 | — | — | WO | disclosed |
| US-10759934-B2 | Thermotropic polymers | QUARZWERKE GMBH (DE) | 2020-09-01 | — | — | US | disclosed |
| US-6809107-B1 | NEURODEGENERATIVE DISEASES | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2004-10-26 | — | — | US | disclosed |
| US-6770644-B1 | Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient | ONO PHARMACEUTICALS CO., LTD. (JP) | 2004-08-03 | — | — | US | disclosed |
| US-6673850-B1 | ODORLESS PHOTOINITIATOR COMPOUNDS HAVING CHAIN TRANSFER GROUPS | CIBA SPECIALTY CHEMICALS CORPORATION | 2004-01-06 | — | — | US | disclosed |
| US-6576728-B1 | Addition copolymerization using a lithium initiator and sodium salt of glycol ether | THE GOODYEAR TIRE & RUBBER COMPANY | 2003-06-10 | — | — | US | disclosed |
| US-6497987-B1 | MIXTURES OF POLYETHERS, ACID GENERATORS AND AMINES THAT MAINTAIN TRANSPARENCY WHEN EXPOSED TO SHORT-WAVELENGTH LIGHT AND HAVE IMPROVED ADHESION TO FILMS, SOLUBILITY TO DEVELOPERS AND ETCH SELECTIVITY; PHOTOLITHOGRAPHY | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2002-12-24 | — | — | US | disclosed |
| EP-1215203-A1 | HYDROXAMIC ACID DERIVATIVES, PROCESS FOR THE PRODUCTION THEREOF AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2002-06-19 | — | — | EP | disclosed |
| US-6245234-B1 | REACTION PRODUCT OF POLYFUNCTIONAL AMINE AND A REACTION PRODUCT OF A POLYFUNCTIONAL TERTIARY AMINE AND AN ACID, AND AN ORGANIC SOLVENT SOLUTION OF AMINE-REACTIVE REACTANT CONSISTING OF A POLYFUNCTIONAL ACYL HALIDE, SULFONYL HALIDE OR | SAEHAN INDUSTRIES INCORPORATION (KR) | 2001-06-12 | — | — | US | disclosed |
| CN-86101774-A | The Pasteurisation process of plasma protein or blood plasma fractions | — | 1987-10-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240059731-A1 | Method for Biomaterial Purification and Kits Thereof | BMP2, ADM2, PLOD3 | TSHR 4366/4885MAPK1 4378/4885MEN1 612/4885 |
| US-20230174688-A1 | COMPOUND, (CO)POLYMER, COMPOSITION, METHOD FOR FORMING RESIST PATTERN, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING (CO)POLYMER | MCCC2, MMAB, INTS9 | TSHR 502/4885MAPK1 1375/4885MEN1 28/4885 |
| US-20080070904-A1 | Pharmaceutical compositions of benzodiazepines and method of use thereof | GABRA5, GABBR1, GABRA6 | TSHR 846/4885MAPK1 4484/4885MEN1 1365/4885 |
| US-20050228191-A1 | Method for preparing hydroxystyrenes and acetylated derivatives thereof | HAAO, EP300, HACL2 | TSHR 4074/4885MAPK1 2996/4885MEN1 3555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.